Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can lifestyle data help close the health gap? new study investigates

NCT ID NCT07558187

Knowledge-focused Sponsor: University of Thessaly Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is collecting information on lifestyle, quality of life, and health markers from 2,000 adults in Greece, including people with chronic diseases, opioid use disorders, and those in prison. The goal is to understand why some groups have worse health and to suggest policies that could help. No treatments are being tested.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could provide evidence to help local and national authorities create targeted health policies and non-drug interventions to reduce health inequalities.
What could go wrong
This is an observational study, not a treatment trial. It will not directly improve health for participants, and the findings may not apply to other regions or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 2,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Sources of study populations: Hospitals; Other health centers and structures in cities, towns or villages; National Organization for the Prevention and Treatment of Addictions (EOPAE); Correctional facilities (prisons)

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults (\>18 years of age) * All healthy individuals who reside in rural and urban areas * All patients with non-communicable diseases who reside in rural and urban areas * Patients with opioid use disorders under medication for addiction treatment with methadone and buprenorphine * Individuals incarcerated in correctional facilities Exclusion Criteria: * Minors (\<18 years of age) * Individuals with communicable diseases

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Addiction to opioids are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Motor Activity Noncommunicable Diseases opiate dependence Smoking

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Addiction to opioids Incarceration Non-communicable diseases (NCD) Opioid use disorders

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    5 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • General Hospital of Larissa

    NOT_YET_RECRUITING

    Larissa, Greece

  • General Hospital of Trikala

    NOT_YET_RECRUITING

    Trikala, Greece

  • Health structures in the Region of Thessaly

    RECRUITING

    Larissa, Greece

  • National Organization for the Prevention and Treatment of Addictions (EOPAE)

    NOT_YET_RECRUITING

    Larissa, Greece

  • National Organization for the Prevention and Treatment of Addictions (EOPAE), Trikala

    NOT_YET_RECRUITING

    Trikala, Greece

More trials for these conditions

Other studies related to the condition(s) this trial covers.